Mary Anne Dunkin

Feature Story

Topical JAK Inhibitor Offers Promise for Two Skin Diseases

09/15/2021

A number of emerging therapies involving the JAK-STAT pathway are in the pipeline for immune-mediated inflammatory diseases. One particular Janus kinase inhibitor shows potential for atopic dermatitis and vitiligo.

A number of emerging therapies...

09/15/2021

The Dermatologist

Feature Story

Treating Zoster-Associated Pain and Postherpetic Neuralgia

10/12/2021

Mary Anne Dunkin ;

Peter Sonnenreich ;

As many as one in five patients with herpes zoster develops zoster-associated pain and/or postherpetic neuralgia. Physicians share their insights on how they treat the sequelae of herpes zoster in their practice.

As many as one in five patients...

10/12/2021

The Dermatologist

Diabetes

How Will Diabetes Trends Affect Wound Clinics in the Future?

03/05/2020

Peter Sonnenreich ;

Lou Savant ;

Natalie Berry ;

Mary Anne Dunkin ;

As the increasing prevalence of diabetes leads to more chronic wounds, how will the wound clinic adjust? Wound care specialists and managed care organizations weigh in on this complex and growing problem.

As the increasing prevalence of...

03/05/2020

Today's Wound Clinic